Funded Tech Companies
Synakis
Synakis, based in Toronto, ON, has financial backing from Chiefswood Holdings, Kickstart Ventures and Toronto Innovation Acceleration Partners.
Company Overview
Company Name
Synakis
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
160 College Street 510
Toronto, ON, M5S 3E1
Canada
Toronto, ON, M5S 3E1
Canada
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Synakis is a pre-clinical biotech startup developing breakthrough biomaterial-based treatments for ocular diseases, including retinal detachment, glaucoma, and retinal degenerative diseases. Our mission is to restore vision and enhance the quality of life for patients. Synakis' core technology, SNK-125, is a proprietary hydrogel specifically designed for ocular delivery. SNK-125 is injectable, biocompatible, biodegradable, non-swelling and transparent. We are developing it as a vitreous replacement for retinal surgery and to deliver engineered therapeutics to treat leading causes of blindness.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/25/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thierry Nivaggioli
Chief Marketing Officer
Robert Devenyi
Chief Scientific Officer
Molly Shoichet
VP - Operations
Jonathan Labriola
VP - R & D
Adam Forman
Company Investors
- Chiefswood Holdings
- Kickstart Ventures
- Toronto Innovation Acceleration Partners
- Ontario Centre of Innovation
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs